Key result
Assessment of thrombogenicity using hemostatic markers and platelet function tests is useful for evaluating stroke subtypes, predicting risk, and monitoring antithrombotic therapy.
Hemostatic markers, particularly D-dimer combined with clinical risk scores, are useful for predicting stroke risk and personalizing antithrombotic therapy, though a comprehensive assessment using multiple markers is required.
Hypothesis-generating for thrombogenicity assessment in stroke; leaves open prospective validation before practice change.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Masako Yamazaki (2017) conducted a review in Stroke. Hemostatic markers and platelet function tests was evaluated. Assessment of thrombogenicity using hemostatic markers and platelet function tests is useful for evaluating stroke subtypes, predicting risk, and monitoring antithrombotic therapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: